Oral phenylalanine and tyrosine tolerance tests in Parkinsonian patients.
Reduction of dopamine concentrations in the brains of patients with Parkinsonism, together with reported clinical improvement after the administration of dihydroxyphenylalanine, has led to the hypothesis that impaired hydroxylation of tyrosine may be associated with the disease. To test this hypothesis oral loading tests with L-phenylalanine and tyrosine were carried out in patients and controls. After phenylalanine lower blood levels of this were found in Parkinsonian patients than in controls, but tyrosine levels were the same. After tyrosine lower levels of this were also found in patients compared with controls. It is suggested that these findings indicate a decreased rate of tyrosine utilization in Parkinson's disease together with intestinal malabsorption; the latter is supported by the finding of abnormal D-xylose tolerance in these patients.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications*; D010649:Phenylalanine / Q000097:blood / Q000378:metabolism*; D013223:Statistics as Topic; D014443:Tyrosine / Q000097:blood / Q000378:metabolism*; D014994:Xylose / Q000378:metabolism / Q000652:urine
D014443:Tyrosine; D010649:Phenylalanine; D014994:Xylose